ARCHIVES

FDA Rejects Genentech Bid For Accelerated Approval For T-DM1. NCI Breaks Ground For Satellite Campus At Shady Grove

This article is from The Cancer Letter archive.

Vol. 36 No. 31 | September 3, 2010

Download PDF Visit The Full Archive

Related Articles

NCI-Approved Clinical Trials Begun At Groups, Centers

November 30, 2007

US Oncology Begins Trial Of Taxotere And Xeloda

September 27, 2002

Five Investigations Probe NIH Radiation Contamination

November 17, 1995

NIH Alternative Medicine Office Releases RFA For Grant Awards

April 9, 1993

Community Center Group To Consider “Clinical Standards, Medical Audit”

September 13, 1974

Guest Editorial: A Near-Term Solution: NCI And COG Agree on Plan to Maintain Enrollment

May 23, 2014